| Website | psilos.com |
| Phone | 212-242-8844 |
| Employees | |
| Founded | 1998 |
Psilos has established itself as a successful healthcare investor and has demonstrated its ability to effectively identify and analyze attractive investment opportunities, to structure and consummate high-quality transactions and to work with entrepreneurial management teams from company inception to successful liquidity events. They understand entrepreneurial drive and the importance of developing relationships with companies that reinforce management’s creative energies.
Psilos seeks investments where they can have a significant positive impact on the strategic development of their portfolio companies, leveraging their broad network of relationships with both strategic and financial investors, corporate partners, investment banks, and industry leaders across the healthcare field.
Psilos invests in businesses that are poised to establish enduring market value by developing fundamental improvements in the healthcare system as a whole.
Psilos seeks to be the lead investor in companies that have:
• An industry-transforming service, technology or product idea;
• A strong, experienced and visionary management team;
• Broad applicability to a large and growing market;
• A compelling and sound business model with superior returns potential;
• Strong intellectual property and high barriers to entry; and,
• Entrepreneurs desirous of forming a strong partnership with their investors
| Company | Date | Round | Size | Participants |
| Gamma Medica-Ideas | 10/09 | Series A | $14M | 2 |
| OmniGuide | 5/08 | Series E | $25M | 7 |
| AngioScore | 10/07 | Series E | $30M | 6 |
| Extend Health | 8/07 | Series B | $15M | 2 |
| Health Hero Network | 11/06 | Series B | $16M | 5 |
